Predicting recurrence after oral precancer treatment: Use of cell cycle analysis

British Journal of Oral and Maxillofacial Surgery

Volumn 46, Issue 5, 2008, Pages 370-375

  Thomson, P J ^a   Hamadah, O ^a   Goodson, M L ^a   Cragg, N ^b   Booth, C ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Epistem Ltd   (United Kingdom)

Author keywords

Cell Cycle; Cyclin A; Cyclin B1; Dysplasia; Oral Precancer; Recurrence

Indexed keywords

CYCLIN A; CYCLIN B1; KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DYSPLASIA; EXCISION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LASER SURGERY; LEUKOPLAKIA; MALE; MOUTH; TONGUE; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; CYCLIN A; CYCLIN B; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KI-67 ANTIGEN; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 44649145834     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2008.01.003     Document Type: Article

References (25)

1. Llewellyn C.D., Linklater K., Bell J., Johnson N.W., and Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 40 (2004) 304-313
2. Thomson P.J., Goodson M.L., Booth C., Cragg N., and Hamadah O. Cyclin A activity predicts clinical outcome in oral precancer and cancer. Int J Oral Maxillofac Surg 35 (2006) 1041-1046
3. Thomson P.J., and Wylie J. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Int J Oral Maxillofac Surg 31 (2002) 145-153
4. Epstein J.B., Zhang L., and Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 68 (2002) 617-621
5. Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. The J Pathol 194 (2001) 294-297
6. Scully C. Oral precancer: preventive and medical approaches to management. Eur J Cancer 3 (1995) 16-26
7. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 14 (2003) 47-62
8. Lind P.O. Malignant transformation in oral leukoplakia. Scand J Dent Res 95 (1987) 449-455
9. Schepman K.P., van der Meij E.H., Smeele L.E., and van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 34 (1998) 270-275
10. Hsue S.S., Wang W.C., Chen C.H., Lin C.C., Chen Y.K., and Lin L.M. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 36 (2007) 25-29
11. Holmstrup P., Vedtofte P., Reibel J., and Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42 (2006) 461-474
12. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane database of systematic reviews (Online) 2006; CD001829.
13. Thomson P.J., Potten C.S., and Appleton D.R. Characterization of epithelial cell activity in patients with oral cancer. Br J Oral Maxillofac Surg 37 (1999) 384-390
14. Thomson P.J., Soames J.V., Booth C., and O'Shea J.A. Epithelial cell proliferative activity and oral cancer progression. Cell Prolif 35 Suppl 1 (2002) 110-120
15. Thomson P.J. Field change and oral cancer: new evidence for widespread carcinogenesis?. Int J Oral Maxillofac Surg 3 (2002) 262-266
16. Lotayef M., Wilson G.D., Daley F.M., Awwad H.K., and Shouman T. Aberrant expression of cyclin A in head and neck cancer. Br J Cancer 83 (2000) 30-34
17. Michalides R., van Tinteren H., Balkenende A., Vermorken J.B., Benraadt J., Huldij J., and van Diest P. Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment. Br J Cancer 86 (2002) 402-408
18. Hassan K.A., El-Naggar A.K., Soria J.C., Liu D., Hong W.K., and Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res 7 (2000) 2458-2462
19. Kushner J., Bradley G., Young B., and Jordan R.C. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J Oral Pathol Med 28 (1999) 77-81
20. Soria J.C., Jang S.J., Khuri F.R., Hassan K., Liu D., Hong W.K., and Mao L. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60 (2000) 4000-4004
21. Egloff A, Vella L A, OJ. F. Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer. Cancer Res 2006; 66: 6-9.
22. Macluskey M., Ogden G.R., Green M., Chisholm D.M., Schor S.L., and Schor A.M. The association between epithelial proliferation and disease progression in the oral mucosa. Oral oncol 35 (1999) 409-414
23. Ha P.K., and Califano J.A. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 14 (2003) 363-369
24. Thomson P.J., and Hamadah O. Cancerisation within the oral cavity: The use of 'field mapping biopsies' in clinical management. Oral oncol 43 (2007) 20-26
25. Thomas G., Hashibe M., Jacob B.J., Ramadas K., Mathew B., Sankaranarayanan R., and Zhang Z.F. Risk factors for multiple oral premalignant lesions. Int J Cancer 107 (2003) 285-291